622 related articles for article (PubMed ID: 16935322)
1. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.
Tapia V; Gabler F; Muñoz M; Yazigi R; Paredes A; Selman A; Vega M; Romero C
Gynecol Oncol; 2011 Apr; 121(1):13-23. PubMed ID: 21236475
[TBL] [Abstract][Full Text] [Related]
3. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer.
Zhu ZW; Friess H; Wang L; Di Mola FF; Zimmermann A; Büchler MW
Anticancer Res; 2000; 20(1A):125-32. PubMed ID: 10769644
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
Shi HR; Song WJ; Chen ZM; Wu QH
Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.
Sowter HM; Corps AN; Evans AL; Clark DE; Charnock-Jones DS; Smith SK
Lab Invest; 1997 Dec; 77(6):607-14. PubMed ID: 9426398
[TBL] [Abstract][Full Text] [Related]
9. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
10. Effects of epidermal growth factor and/or nerve growth factor on Malassez's epithelial rest cells in vitro: expression of mRNA for osteopontin, bone morphogenetic protein 2 and vascular endothelial growth factor.
Yamawaki K; Matsuzaka K; Kokubu E; Inoue T
J Periodontal Res; 2010 Jun; 45(3):421-7. PubMed ID: 20337888
[TBL] [Abstract][Full Text] [Related]
11. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
12. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
13. Presence of NGF and its receptors in ovaries from human fetuses and adults.
Abir R; Fisch B; Jin S; Barnnet M; Ben-Haroush A; Felz C; Kessler-Icekson G; Feldberg D; Nitke S; Ao A
Mol Hum Reprod; 2005 Apr; 11(4):229-36. PubMed ID: 15829579
[TBL] [Abstract][Full Text] [Related]
14. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor and its precursor differentially regulate hair cycle progression in mice.
Peters EM; Hendrix S; Gölz G; Klapp BF; Arck PC; Paus R
J Histochem Cytochem; 2006 Mar; 54(3):275-88. PubMed ID: 16009967
[TBL] [Abstract][Full Text] [Related]
16. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
17. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Abeler VM; Kopolovic J; Onsrud M; Lazarovici P; Davidson B
Hum Pathol; 2007 Jan; 38(1):140-6. PubMed ID: 16996570
[TBL] [Abstract][Full Text] [Related]
18. Stress alters vascular-endothelial growth factor expression in rat arteries: role of nerve growth factor.
Manni L; Antonelli A; Costa N; Aloe L
Basic Res Cardiol; 2005 Mar; 100(2):121-30. PubMed ID: 15739121
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells.
Abe Y; Akeda K; An HS; Aoki Y; Pichika R; Muehleman C; Kimura T; Masuda K
Spine (Phila Pa 1976); 2007 Mar; 32(6):635-42. PubMed ID: 17413467
[TBL] [Abstract][Full Text] [Related]
20. NGF/TRKA Decrease miR-145-5p Levels in Epithelial Ovarian Cancer Cells.
Garrido MP; Torres I; Avila A; Chnaiderman J; Valenzuela-Valderrama M; Aramburo J; Oróstica L; Durán-Jara E; Lobos-Gonzalez L; Romero C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]